This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Based in North Kansas City, MO, Cerner Corporation (CERN) provides healthcare information technology (HCIT) solutions worldwide. The company offers software and hardware solutions that give healthcare providers secure access to clinical, administrative and financial data in a short time. As of February 2018, its products were in use at more than 27,000 facilities around the world. The company had more than 28,000 employees globally, with over 13,000 in Kansas City, Missouri. More than 28,000 Cerner associates are currently employed in 26 countries worldwide
Allscripts (MDRX) & Appriss Health Collaborate to Fight SUD
by Zacks Equity Research
Allscripts' (MDRX) EHR solutions have lucrative prospects.
Here's Why You Should Hold on to Cerner (CERN) Stock for Now
by Zacks Equity Research
Cerner (CERN) likely to gain from focus on big-data based healthcare services.
Veeva's Technology Partner Joins Verix to Boost CRM Platform
by Zacks Equity Research
Veeva Systems' (VEEV) focus on cloud-based services is likely to favor the stock.
Here's Why You Should Hold on to Allscripts (MDRX) Stock Now
by Zacks Equity Research
Strong prospects in Sunrise EHR platform to aid Allscripts (MDRX). However, intense competition in the MedTech space is a headwind.
Cerner CommunityWorks Selected by Pershing Health System
by Zacks Equity Research
Cerner (CERN) witnesses consistent growth in the Electronic Health Record platform and Revenue Cycle Management solutions.
NextGen Rides on Prospects in RCM Space, Competition Rife
by Zacks Equity Research
NextGen (NXGN) is a major player in the U.S. RCM market. However, the company faces cutthroat competition in the healthcare information systems and services market.
Cerner's CommunityWorks Picked by Reeves County Hospital
by Zacks Equity Research
Cerner (CERN) sees a slew of developments in its EHR platform, market prospects bright.
Cerner Integrated Platform Implemented by Spectrum Health
by Zacks Equity Research
Spectrum Health selects Cerner's (CERN) Cerner Integrated Platform to treat psychological disorders.
Veeva's Vault CDMS to Unify Clinical Data in Single Platform
by Zacks Equity Research
Veeva's (VEEV) cloud-based applications' market prospects bright.
Veeva Gains as MD&D Companies Pick Its Cloud-Based Services
by Zacks Equity Research
Veeva's (VEEV) focus on cloud-based services is likely to open up substantial opportunities for the company.
Medical Services Boom Drives Healthcare: 3 Top Picks
by Sreyoshi Mukherjee
Considering the rising popularity of PBM, CRO and EHR in the U.S. Medical Services industry, these three picks might be money-spinning choices for investors.
Cerner, Duke Clinical Research Launch Risk Calculator App
by Zacks Equity Research
Cerner (CERN) launches new Risk Calculator app that will check cardiac risk. The company's relentless efforts to digitize its EHR systems is commendable.
Cerner (CERN) Strong on EHR Prospects, Competition Intense
by Zacks Equity Research
Cerner's (CERN) strong EHR prospects and global outlook aid the company; margins continue to decline.
Allscripts' Payerpath & ePrescribe Receive EHNAC Accreditation
by Zacks Equity Research
Accreditation by EHNAC indicates Allscripts' (MDRX) sustainability in health data processing and transactions in terms of industry-established standards and HIPAA regulations.
Cerner (CERN) Looks Good: Stock Adds 6.2% in Session
by Zacks Equity Research
Cerner (CERN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Cerner (CERN) Beats Q2 Earnings Estimates, Bookings Rise Y/Y
by Zacks Equity Research
Cerner (CERN) gains from solid bookings growth in Q2; developments in the EHR front are promising.
Cerner (CERN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cerner (CERN) delivered earnings and revenue surprises of 3.33% and 3.11%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Medical Product Earnings Lineup for Aug 2: ABC, BDX & More
by Zacks Equity Research
Strong R&D focus is likely to be the key driver of the Medical Product space in Q2.
What's in Store for Cerner (CERN) This Earnings Season?
by Zacks Equity Research
Cerner's (CERN) Q2 results are likely to show softer performance owing to declining revenues across core business segments.
Medical Info Systems Stock Outlook: Short-Term Pain to Stay
by Zacks Equity Research
The ongoing digital transition is accelerating demand for IT service solutions in healthcare despite legal and regulatory hurdles.
Patterson's (PDCO) NaVetor Launch to Boost Animal Health Unit
by Zacks Equity Research
Patterson Companies (PDCO) collaborates with Cure Partners to form a new business; launches NaVetor for Animal Health Unit.
New Strong Sell Stocks for June 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Here's Why You Should Steer Clear of Cerner (CERN) for Now
by Zacks Equity Research
Cerner's (CERN) downbeat view for 2018 and soft segmental performances fail to cheer investors.
CPSI vs. CERN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CPSI vs. CERN: Which Stock Is the Better Value Option?
New Strong Sell Stocks for June 7th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: